TUBERCULOSIS (TB)
TUBERCULOSIS (TB)
An
infectious disease spread by airborne route. Infection is caused by inhalation of
droplets that contain the tuberculosis bacteria (Mycobacterium tuberculosis).
An infected person can spread the small airborne particles through coughing, sneezing,
or talking. Close contact with those affected increases the chances of transmission.
Once inhaled, the organism typically settles into the lung, but can infect any
organ in the body. The organism has an outer capsule.
PATHOPHYSIOLOGY
Primary
TB occurs when the patient is initially infected with the mycobacterium.
After
being inhaled into the lung, the organism causes a localized reaction. As the
macrophages and sensitized T-lymphocytes attempt to isolate and kill off the
mycobacterium within the lung, damage is also caused to the surrounding lung
tissue. A well-defined granulomatous lesion develops that contains the mycobacterium,
macrophages and other cells. Necrotic changes occur within this lesion. Caseous
granulomas develop along lymph node channels during the same time. These areas
create a Ghon’s complex which is a combination of the area initially infected
by the airborne bacillus called the Ghon’s focus and a lymphatic lesion. The
majority of people with newly acquired infections and an adequate immune system
will develop latent infection, as the body walls off the infecting organism
within these granulomas. Disease is not active in these patients at this point
and will not be transmitted until there is some manifestation of the disease.
In
patients with inadequate immune response, the tuberculosis will be progressive,
lung tissue destruction will continue, and other areas of the lung will also
become involved. In secondary TB, the disease is reactivated at a later stage.
The patient may be reinfected from droplets, or from a prior primary lesion.
Since the patient has previously been infected with TB, the immune response is
to rapidly wall off the infection.
Cavitation
of these areas occurs as the organism travels along the airways. Exposure to TB
occurs when a person has had recent contact with a person suspected or
confirmed having TB. These patients do not have positive skin test, signs or
symptoms of disease, or chest x-ray changes. They may or may not have disease.
Latent
TB infection occurs when a person has a positive tuberculin skin test but no
symptoms of disease. Chest x-ray may show granuloma or calcification. of
drug-resistant organisms. Initial treatment times generally range from 6 to 12 months.
Longer treatment plans may be necessary for those with HIV infection or drug-resistant
strains of TB. Some patient populations are monitored closely for compliance
with direct observation of drug treatment. Patient teaching is important for
medication protocol compliance and monitoring for side effects. Repeat sputum cultures
are typically taken to see that the treatment for active disease is effective.
•
Administer antitubercular medications to treat and prevent transmission:
•
Isoniazid, rifampin, pyrazinamide, ethambutol, streptomycin
•
Respiratory isolation for in-hospital care—the bacteria is spread by droplet.
•
Increase protein, carbohydrates, and vitamin C diet for patients.
TB
disease is confirmed when a person has signs and symptoms of tuberculosis. The
chest x-ray typically has abnormalities in the apical aspects of the lung
fields. In HIV patients other areas may also be affected.
PROGNOSIS
Some
patients develop drug-resistant TB, making treatment more difficult. The drug-resistant
TB may be resistant at the time of initial infection, or may develop as a
result of medications during treatment. This occurs either because the
treatment was not adequate or not taken appropriately.
SIGNS
AND SYMPTOMS
•
Weight loss and anorexia
•
Night sweats
•
Fever, possibly low-grade, due to infection
•
Productive cough with discolored, blood-tinged sputum
•
Shortness of breath due to lung changes
•
Malaise and fatigue due to active illness affecting lungs
INTERPRETING
TEST RESULTS
•
Positive Mantoux (PPD) skin test shows exposure to tuberculosis due to development
of cell-mediated immunity; typically takes between 2 and 10 weeks from time of
exposure.
•
Chest x-ray may show areas of granuloma or cavitation.
•
Sputum test identifies M. tuberculosis bacteria:
•
Acid fast-staining done to initially screen for TB—bacillus will hold stain
•
Culture confirms the diagnosis but is slow-growing.
TREATMENT
Patients
with active TB are initially placed on respiratory isolation as inpatients to reduce
the risk of spreading the organism by droplet infection or aerosolization. Medications
are initiated to treat TB and prevent transmission to others. Treatment may be
initiated for active disease or for those without active disease who have had recent
exposure. Combination therapy is typically used to decrease the likelihood.
Comments
Post a Comment